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Abstract
Infection of adherent cell monolayers using a liquid inoculum represents an established method to 
reliably and quantitatively study virus infection, but poorly recapitulates the exposure and 
infection of cells in the respiratory tract that occurs during infection with aerosolized pathogens. 
To better simulate natural infection in vitro, we adapted a system that generates viral aerosols 
similar to those exhaled by infected humans to the inoculation of epithelial cell monolayers. 
Procedures for cellular infection and calculation of exposure dose were developed and tested using 
viruses characterized by distinct transmission and pathogenicity phenotypes: an HPAI H5N1, an 
LPAI H7N9, and a seasonal H3N2 virus. While all three aerosolized viruses were highly infectious 
in a bronchial epithelial cell line (Calu-3) cultured submerged in media, differences between the 
viruses were observed in primary human alveolar epithelial cells and in Calu-3 cells cultured at 
air-liquid interface. This system provides a novel enhancement to traditional in vitro experiments, 
particularly those focused on the early stages of infection.
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Introduction
Infection of adherent cell monolayers using a liquid inoculum represents an established 
method to reliably and quantitatively study virus infection. Relatively straightforward and 
inexpensive, this method allows for the frequent collection of viral samples and the testing 
of a variety of experimental conditions and discrete cell types including those of human 
origin. Unfortunately, traditional in vitro replication studies poorly recapitulate the exposure 
and infection of cells in the respiratory tract that occurs during natural exposure to 
aerosolized pathogens. Not only does infection occur while cells’ apical surface is immersed 
in liquid, but at typical cell densities, the often-used “low” multiplicity of infection (MOI) of 
0.01 corresponds to a dose of over a thousand PFU per square centimeter.
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Available evidence suggests that in the case of aerosol transmission, natural human influenza 
infection is likely initiated by substantially fewer particles. Studies of infected patients found 
low viral concentrations in aerosols generated by breathing, coughing, and/or sneezing 
(Fabian et al., 2008; Milton et al., 2013; Yang et al., 2011), and fewer than five TCID50 are 
capable of initiating symptomatic infection in experimentally exposed volunteers (Alford et 
al., 1966). Similar results have been observed in the ferret model; these animals can be 
infected with fewer than ten PFU and subsequently exhale under five PFU per minute 
(Gustin et al., 2015; Gustin et al., 2011; Gustin et al., 2013; Roberts et al., 2011). Using a 
library of barcoded viruses, Varble et al. found that respiratory droplet transmission between 
ferrets involved only single-digit numbers of virions (Varble et al., 2014). Reports of 
A(H7N9) cases developing subsequent to patient visits to live bird markets despite lack of 
poultry contact, and the detection of virus in air sampled from such markets, indicate that 
zoonotic infection may also occur after human exposure to low quantities of aerosolized 
virus (Li et al., 2015; Liu et al., 2014; Zhou et al., 2016).
In order to better study the effects of potentially damaging aerosols on human cells, the 
toxicology field has begun to expose cultured respiratory epithelial cells to aerosolized, 
rather than liquid-suspended, chemical and particulate matter. Cells have been shown to be 
more sensitive to the effects of the former (Bitterle et al., 2006; Raemy et al., 2012). In these 
studies, aerosol concentration can be measured by the use of optical or gravimetric methods. 
These types of methods are not effective for the measure of virus-containing aerosols, 
however, because they detect liquid droplet nuclei rather than the virus within them, and 
cannot differentiate between infectious and non-infectious virions. Microbiologists have 
developed aerosolization systems to overcome these challenges, and have used them for 
experimental infections of animals and to study the effect of environmental conditions on 
viability of numerous pathogens including Mycobacterium tuberculosis, Bacillus anthracis, 
measles virus, and influenza virus (Clark et al., 2011; Gustin et al., 2011; Lemon et al., 
2011; Savransky et al., 2013). This work has provided important insights into the intra- and 
inter-host spread of these pathogens by facilitating the observation and manipulation of near-
natural infection within a controlled laboratory environment. However, despite the frequent 
employment of in vitro studies to complement animal experimentation, use of an aerosol 
system for in vitro infection with any pathogen has not, to our knowledge, been previously 
described.
We combined aspects of the toxicological and microbiological approaches to establish a 
novel method to expose adherent mammalian cell monolayers in air-liquid interface to 
defined quantities of aerosolized influenza virus and compared this with traditional liquid 
inoculation. In order to most effectively mimic the conditions of natural infection, we 
explored the use of very low MOI infection and culture techniques designed to promote cell 
differentiation in conjunction with virus aerosolization. Using highly pathogenic avian 
influenza (HPAI), low pathogenic (LPAI), and seasonal influenza viruses, we demonstrate 
that infection of respiratory epithelial cells with physiologically low concentrations of 
aerosolized virus can be successfully recreated inside the laboratory. In conjunction with 
research using animal models, these techniques facilitate a closer study of the infectivity of 
aerosolized influenza virus in the context of human infection. The approach described here 
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is not restricted to influenza virus and would also be applicable to the study of other 
respiratory viruses of public health concern.
Materials and Methods
Viruses
Influenza A viruses were propagated in the allantoic cavity of 10-day-old embryonated hens’ 
eggs and titered via standard plaque assay using Madin-Darby canine kidney (MDCK) cells 
as previously described (Maines et al., 2005; Zeng et al., 2007). All experiments were 
conducted under biosafety level 3 containment, including enhancements as required by the 
U.S. Department of Agriculture and the Federal Select Agent Program (Chosewood et al., 
2009).
Cell culture and liquid inoculations
The bronchial epithelial cell line Calu-3 (ATCC) was cultured as previously described (Zeng 
et al., 2007). Primary human alveolar epithelial cells (Cell Biologics) were cryopreserved at 
passage 3, then grown and expanded per manufacturer’s instructions. All cells were seeded 
on 24 mm diameter (6-well format) or 12 mm diameter (12-well format) semipermeable 
membrane inserts with a 0.4µm pore size (Corning) and grown to confluence under 
submerged conditions. After reaching a transepithelial resistance of >1,000 Ω2 (Zeng et al., 
2007), apical media was removed from selected Calu-3 cells to create an air-liquid interface 
(ALI), which was maintained for three weeks to facilitate cell differentiation and the 
establishment of a mucin layer.
Prior to inoculation, apical media (if present) was removed from the cell monolayer and 
cells cultured under submerged conditions were washed to remove serum present in culture 
media. Liquid inoculation was performed using 300µL of virus, diluted as specified in the 
results, and incubated on the cell surface for one hour before washing. After infection, cells 
were cultured in cell type-specific serum-free medium to which 1µg/mL N-p-tosyl-L-
phenylalanine chloromethyl ketone (TPCK)-treated trypsin (Sigma-Aldrich) was added for 
alveolar cell cultures. Aliquots of apical culture supernatant or wash media (incubated atop 
cells cultured at ALI for 20 minutes) were collected at the indicated times post-infection 
(p.i.) and immediately frozen at −80°C until titration. Growth curves were generated and 
analyzed using Prism 6.0.7 (GraphPad Software Inc.).
Aerosol inoculations
The automated bioaerosol system used for all experiments has been previously described in 
detail (Gustin et al., 2011; Hartings and Roy, 2004) and all conditions were maintained here 
unless specified otherwise. Briefly, virus suspended in a solution of PBS-0.03% (w/v) BSA 
was aerosolized using a three-jet Collision nebulizer (BGI, Inc.) and passed through an 
exposure chamber at a rate of 20 L/min. Cells placed inside the exposure chamber on a wire 
mesh shelf were inoculated under air-liquid interface conditions (Fig. 1). Using the AeroMP 
(Biaera Technologies) aerosol management platform, aerosol exposures were conducted at 
21°C and 50% relative humidity for 15 min followed by a 5 min purge to allow evacuation 
of the aerosolized virus from the chamber (Gustin et al., 2011). Prior to in vitro exposure, 
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spray factor (SF) values were determined for stocks of all viruses to estimate the starting 
virus concentration in the nebulizer needed to obtain a desired quantity of virus in the 
aerosol. A Biosampler (SKC Inc) was used to quantify the virus actually aerosolized within 
the chamber during each exposure. Following aerosol exposure, membrane inserts were 
transferred to clean 6-well or 12-well plates and serum-free medium was added to apical and 
basolateral compartments as described above; cells maintained under ALI conditions had 
medium added to the basolateral compartment only. Confirmation of cell viability during 
aerosol exposure was performed using the WST-1 cell proliferation reagent (Roche Applied 
Science), according to manufacturer’s instructions, with four independent samples tested for 
each condition.
Quantitation of Exposure and Infectious Doses
The total number of infectious virions passed through the chamber during the exposure 
session (Ncham) was calculated as
where Csamp is the concentration of virus in the sampler, Vsamp is the volume of media in the 
sampler, and Qcham and Qsamp represent the flow rates of chamber and sampler, respectively 
(see supplemental methods for derivation). Ncham was multiplied by the ratio of the surface 
area of each transwell (SA) to the cross-sectional area of the chamber (XA) to yield 
exposure dose (ED). ID50s were calculated according to the method of Reed and Muench, 
with the proportional distance multiplied by log10(dose above 50%)/log10(dose below 50%) 
to account for the deviation of exposure doses from exact 10-fold dilutions (Reed and 
Muench, 1938). Variability around the mean exposure dose was quantified using a binomial 
model with n viable virions passing through the chamber and a probability of success (virion 
lands on well) equal to SA/XA. Upper and lower critical values at the 95% confidence level 
were calculated using R 3.2.3 (R Foundation for Statistical Computing); the true exposure 
dose for any particular well has a 95% chance of falling between these two values. The 
cumulative probability distribution indicated that the minimum dose had to be three or 
greater for 95% of all wells to be inoculated with at least one virion. In order minimize the 
chance of including a well not exposed to any virus, we therefore aimed not to use mean 
exposure doses under 5 PFU. When this did occur due to variations in aerosolization 
efficiency, the minimum 50% infectious dose is reported as ≤ 3 PFU.
Real-time RT-PCR
Total RNA was extracted from mock-infected or virus-infected cell monolayers after 
removal of supernatant using the RNeasy mini kit (Qiagen). RT-PCR was performed with a 
QuantiTect SYBR green RT-PCR kit (Qiagen) in duplicate reactions from duplicate samples 
using an influenza A virus M1 gene primer set (Zeng et al., 2007). Influenza virus M gene 
RNA copy numbers were extrapolated using a standard curve based on samples of known M 
gene copy number.
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System establishment and exposure dose determination
Rather than use the type of exposure system described in studies of cellular responses to 
aerosolized particulate matter (eg. CULTEX Radial Flow System), we employed one 
intended for use in animal infection. Previously optimized for use with influenza virus 
(Gustin et al., 2011), this system and its components are designed to maintain the viability of 
biological aerosols. This system features a large exposure chamber, which allows for 
simultaneous exposure of several plates of cells, facilitating comparisons of different cell 
types or growth conditions between uniformly exposed wells (Fig. 1).
In vitro inoculations of cells grown on semi-permeable membrane inserts (transwells) were 
conducted as follows: apical media (if present) was removed immediately prior to exposure, 
then plates holding the inserts and basolateral media were placed in the chamber and 
exposed to ten-fold serial dilutions of aerosolized virus for a duration of 15 minutes. 
Following exposure, inserts were transferred to a sterile tissue culture plate containing fresh 
basolateral media and apical media was replaced. Mock infection led to no significant 
decrease in cell viability (data not shown), indicating that the presence of basolateral media 
was sufficient to keep the cells from drying out during exposure.
The ability to quantitate the dose to which an animal or cell monolayer is exposed is a 
critical component of experiments utilizing aerosol-based exposure systems (Hartings and 
Roy, 2004), and is necessary for comparison of aerosol infections with those conducted by 
the more traditional liquid route. We found that titration of virus collected in wells of media 
placed in the chamber alongside the cells was insufficiently sensitive to reliably quantify the 
low doses to which each monolayer was exposed (data not shown), possibly because 
deposition efficiency differed between the cell surface and the liquid media. We therefore 
modeled our approach on that used in aerosol inoculation of animals. Presented dose for an 
animal can be expressed as the total number of infectious virions passing through the 
chamber during an exposure session multiplied by the ratio of the volume of aerosol inhaled 
by the animal to the total volume of aerosol passed through the chamber (see supplemental 
methods for derivation). For in vitro quantification, we substituted the ratio of the surface 
area of each transwell insert to the cross-sectional area of the chamber for the ratio of 
inhaled to total aerosol volume. Because the efficiency of particle deposition on the cell 
surface was estimated to be approximately 100%, presented dose and exposure dose were 
considered equivalent. No correlation between plate position within the chamber or well 
position within the plate and virological outcome was observed.
Validation of experimental approach
Initial characterization studies were conducted using the Calu-3 human bronchial epithelial 
cell line. This cell type is relevant to respiratory infection and has previously been shown to 
support replication of a variety of influenza A viruses, though published studies have 
typically used MOIs of 0.01 (equivalent to 10,000 TCID50 or PFU per 24mm well) or higher 
(Zeng et al., 2007; Zhou et al., 2011). In order to generate comparison data for aerosol 
infections, we first conducted an analogous experiment using traditional liquid inoculation at 
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a wide range of doses. Two influenza viruses known to replicate with high efficiency (A/
Thailand/16/2004 [Thai/16, HPAI A(H5N1)] and A/Anhui/1/2013 [Anhui/1, LPAI 
A(H7N9)], both isolated from fatal human cases) were serially diluted and used to inoculate 
quintuplicate wells. Because of the potential for both random and systemic error in making 
repeated serial dilutions, we titrated all inocula, enabling us to more precisely estimate the 
number of infectious virions to which each well was exposed. RNA was collected from the 
cell monolayers of two wells 24 hours post-inoculation and assayed for the presence of viral 
nucleic acid via RT-PCR with primers specific to the M1 gene. Growth kinetics in the 
remaining three wells were monitored by titration of cell supernatants collected between 2 
and 96 hours post-infection (Fig. 2). At inoculum doses above our limit of detection (10 
PFU/mL or 3 PFU/well), both viruses consistently infected all replicate wells and replicated 
to high titer, though growth was somewhat delayed at lower inoculation doses relative to 
higher ones (Figs. 2, 3B). We also observed robust replication in cultures inoculated with 
approximately 1 PFU (dose estimated from serial dilution) of Anhui/1 virus. At doses of less 
than one PFU, infection was infrequent, characterized by low titers and undetectable levels 
of viral nucleic acid in the cell monolayer 24 hours after inoculation.
Aerosol experiments were conducted with three viruses chosen to represent a diversity of 
mammalian in vivo pathogenicity and transmissibility phenotypes: Thai/16, Anhui/1, and A/
Panama/2007/99 (Panama/99, seasonal A(H3N2)). All three viruses infected Calu-3 cells 
with high efficiency following aerosol exposure (Fig. 3). We observed rates of productive 
infection comparable to those seen after inoculation using a liquid suspension, with 50% 
infectious doses (ID50s) for all three viruses of under five PFU. High peak viral titers (108 
PFU/ml) were detected in the supernatant regardless of exposure dose, though, as with liquid 
inoculum, replication was delayed at lower inoculation doses (Fig. 3). Duplicate cultures 
were incubated post-exposure at 33°C, a temperature thought to represent that of the 
mammalian upper respiratory tract, after infection to see whether infectivity was 
temperature-dependent. We found that while 24-hour titers of the two avian viruses were 
slightly lower at this temperature than at 37°C, infectivity of these cultures was reduced only 
for Panama/99 virus, and only slightly (ID50 of 12 vs ≤ 3 PFU).
The concordance in infectious dose between aerosol and liquid inoculations suggested that 
our calculated exposure dose for each well accurately represented the average number of 
virions to which a well was truly exposed. To confirm this, we conducted a series of 
exposures at doses near 1 PFU (range 0.02 to 7 PFU) per well. In light of our liquid 
exposure data with Thai/16 and Anhui/1, we reasoned that if the calculated exposure doses 
were accurate, the majority of Calu-3 wells should be infected with either of these viruses at 
doses ≥1 PFU, whereas few wells would be infected at doses <1 PFU. Consistent infection 
at calculated doses under 1 PFU would indicate that the true exposure dose was higher than 
the calculated one. Conversely, infrequent infection at doses ≥1 PFU would suggest that the 
actual exposure dose was less than the calculated one. In order to conduct a quantitative 
analysis, we determined the number of wells we would expect to become infected after each 
set of exposures using a Poisson binomial model (Hong, 2013). We statistically compared 
the expected number of infected wells (based on our calculated exposure dose) to the 
number of wells observed to be infected in our experiment (reflective of actual exposure 
dose) (Table 1). Even though our tests were highly powered (≥ 99% chance of detecting a 
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half-log difference between true and calculated exposure doses if a difference was present), 
we did not detect such a difference for either of the viruses tested (p>0.05). This suggested 
that our estimation of 100% deposition efficiency did not compromise our exposure dose 
estimates.
Infection of primary human alveolar cells
Having validated our methodology using a transformed cell line, we next investigated the 
ability of low-dose aerosols to infect primary human alveolar epithelial cells. Seasonal 
influenza A viruses are typically restricted to the upper respiratory tract during infection of 
humans and mammalian models, while avian viruses are often detected in the lungs. 
However, multiple in vitro studies have found primary human alveolar cells to be permissive 
for the replication of human influenza viruses (Weinheimer et al., 2012; Yu et al., 2011). We 
hypothesized that this discrepancy might be an artifact caused by the artificial nature of the 
liquid inoculum used in the in vitro studies. After confirming that liquid-based inoculation 
with Thai/16, Anhui/1, and Panama/99 viruses at an MOI of 0.01 led to productive 
replication in primary human alveolar cells (Figs. 4A and 4C), we exposed the alveolar cells 
to multiple concentrations of the same three viruses, this time by the aerosol route. Thai/16 
virus was highly infectious, replicating productively in wells exposed to an average of ≤ 3 
PFU (MOI = 2.6×10−6). In contrast, replication of Panama/99 or Anhui/1 viruses could not 
be detected at any of the doses tested following aerosol inoculation (Fig. 4A). Repetition of 
the highest-dose aerosol inoculation confirmed the absence of detectable replication of 
Anhui/1 virus (Fig. 4C). Low levels of Panama/99 virus were present in the cell supernatant 
of all three triplicate wells, but in all cases, titers peaked 24 hours post-infection and 
declined thereafter, indicating unsustained or unproductive replication. To determine 
whether the lack of replication was a product of inoculation route or dose, we exposed cells 
to a liquid inoculum at an MOI (~0.001) equivalent to that of our most concentrated aerosol 
inoculation. Growth kinetics were similar to those observed after the 0.01 MOI infections, 
suggesting that the lack of replication in a permissive cell type could be attributed to the 
aerosol delivery of the virus and not to its low concentration.
Infection of cells cultured under air-liquid interface
In order to reach susceptible cells, inhaled pathogens must penetrate the mucus layer coating 
the airway epithelium. The mucus layer and epithelium can be simulated in vitro by 
culturing respiratory cell lines or primary cells at air-liquid interface (ALI: media is present 
only on the basolateral side of the monolayer, with the apical side left exposed to air). 
Culture at ALI causes cells to differentiate and form a pseudostratified, columnar 
epithelium, comprising multiple cell types, including mucus-secreting goblet cells (Kreft et 
al., 2015). However, it has not previously been possible to recreate the interaction of 
aerosolized pathogens with respiratory mucus in an in vitro setting. We therefore compared 
the susceptibility of Calu-3 cells grown at ALI and liquid-liquid interface (LLI: media 
present on apical and basolateral sides) to infection with aerosolized virus. Infectivity of 
Calu-3 cells cultured at ALI for three weeks (sufficient to induce substantial mucus 
production (Haghi et al., 2010; Kreft et al., 2015)) varied by virus (Fig. 5): Panama/99 
infectivity was only slightly abrogated (ID50 increased from ≤ 3 to 7) whereas Thai/16 and 
Anhui/1 were over 25 times less infectious in the ALI-cultured cells than those cultured at 
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LLI. When cells were successfully infected with any of the viruses, replication was delayed 
and reached lower titers in ALI cultures as compared to LLI (Fig. 5). Together, these data 
demonstrate that the capacity for aerosolized inocula to infect cultures of differentiated 
human airway cells is abrogated but not eliminated by the presence of a mucin layer.
Discussion
While a growing body of work describes the characteristics of aerosolized microbes, the 
interaction of pathogen-laden aerosols with the airway epithelium has not been specifically 
examined. We demonstrate here that infection of adherent cell monolayers by aerosol is 
feasible, and we describe and validate a straightforward method for the calculation of 
exposure dose, which facilitates comparison between infections using liquid and aerosol 
inocula. While in vitro replication studies typically measure viral titers over time after 
infection with a single MOI, we found that measuring viral infectivity at a variety of MOIs 
was more informative.
Measurements of infectivity may also be more relevant to virus transmission. Interestingly, 
we found that culture of Calu-3 cells at 33°C post-aerosol-inoculation did not significantly 
reduce the ability of any of the viruses tested to establish infection. While we did not 
perform a liquid comparison, we would expect comparable results given the consistency of 
replication of the tested viruses in this cell type. It is important to note, however, that all 
three viruses have a lysine at position 627 of the PB2 gene rather than a glutamate, which is 
known to restrict replication at this temperature (Neumann and Kawaoka, 2015). More 
significant effects on infectivity might be observed with viruses that have a glutamate at this 
position or in other cell types.
Studies utilizing very low MOI may play an important role in advancing our understanding 
of influenza virus transmission by simulating in vitro the conditions under which infection is 
first established in a new human host. At decreased MOI, for example, the rate at which 
semi-infectious particles are able to replicate synergistically through cellular co-infection is 
reduced (Fonville et al., 2015), but the diminished proliferation of defective interfering 
particles may lessen innate immune activation, thereby allowing for increased viral 
replication. Indeed, previously published work with influenza and other viruses describes 
differences in viral replication at high and low MOI (Aggarwal et al., 2011; Huh et al., 2008; 
Miller et al., 1994). We have demonstrated here the feasibility of studies using very low 
MOI; though we observed only subtle changes in replication kinetics as MOI decreased, 
similar across all viruses tested, more pronounced effects may be observed with other 
viruses, cell types, and/or culture conditions (e.g. temperature).
Droplet nuclei (<5µm) containing virus, unlike larger (>5µm) droplets or virus present on 
surfaces, reaches the lower respiratory tract when inhaled (BeruBe et al., 2009). We were 
therefore particularly interested in the ability of aerosolized virus to infect primary human 
alveolar cells. We found that both the seasonal virus Panama/99 and an outbreak-associated 
A(H7N9) virus, Anhui/1, replicated productively in primary human pneumocytes after 
inoculation via the liquid, but not aerosol, route whereas the HPAI virus Thai/16 was highly 
infectious and replicated to high titer regardless of inoculation method. For Panama/99 virus, 
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these in vitro results are consistent with both ferret studies, which do not detect virus 
replication in the lungs, and with human seasonal virus infections, which are typically 
limited to the upper respiratory tract. In contrast, severe human A(H7N9) cases have been 
characterized by symptoms of lung infection (Chen et al., 2013; Gao et al., 2013; Hu et al., 
2013; Yang et al., 2014; Yu et al., 2013b), and virus has been detected in the lungs of 
experimentally infected animals (Belser et al., 2013; de Wit et al., 2014; Gabbard et al., 
2014; Watanabe et al., 2013; Xu et al., 2014; Zhang et al., 2013; Zhu et al., 2013). Our 
findings raise the possibility that the development of viral pneumonia associated with H7N9 
virus develops not upon initial exposure, but subsequent to viral spread from adjacent 
tissues, and warrant further investigation regarding the dynamics of H7N9 virus infection 
throughout the respiratory tract. The need for such spread may provide a window of 
opportunity for the immune system to restrict the virus before it causes severe disease, 
which would explain the apparent prevalence of clinically inapparent and mild infection with 
this virus (Chen et al., 2014; Ip et al., 2013; Yu et al., 2013a).
Using the Calu-3 cell line, we demonstrated that growth under ALI conditions reduced the 
efficiency of both initial infection and subsequent viral replication. The high viscosity of 
mucus and abundance of virus-binding sialic acids may limit the diffusion of virus between 
cells, thereby reducing viral titers. Notably, abrogation in infectivity resulting from culture at 
ALI was more pronounced with the two avian viruses tested than the seasonal virus 
Panama/99. This finding is consistent with the hypothesis that respiratory mucus serves as 
an important barrier to the ability of avian influenza viruses to transmit between humans, 
possibly because their specificity for α2,3-linked sialic acids makes them more susceptible 
to binding and entrapment by mucus, which some studies have suggested contains glycans 
primarily in the α2,3 conformation (Baum and Paulson, 1990; Couceiro et al., 1993). Use of 
reverse genetics techniques to compare viruses differing only in the sialic binding 
preferences of the hemagglutinin and/or neuraminidase proteins will allow for further 
investigation of this phenomenon.
Aerosol inoculation, particularly when used in conjunction with increasingly sophisticated 
techniques for in vitro cell culture, offers a unique opportunity to study virus-cell 
interactions in an environment resembling that of the human respiratory tract. Our studies 
suggest that aerosol inoculation may enhance studies of viral tropism and improve our 
understanding of the effects of environmental conditions on the ability of influenza virus to 
initiate infection. Continued investigation regarding the role of inoculation route in viral 
binding and entry processes will further our understanding of the infectivity of influenza 
viruses with distinct phenotypes. In addition to influenza, the methods outlined here could 
be used for the study of other respiratory viruses such as severe acute respiratory syndrome 
(SARS) virus, varicella zoster virus (VZV), and measles virus, as well as the risk assessment 
of novel pathogens. The ability to combine aerosol inoculation with the benefits of in vitro 
study, notably the ability to study specific cell types in isolation, will facilitate a greater 
understanding of the infectivity and tropism of respiratory pathogens of public health 
concern.
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Figure 1. Graphic representation of aerosol system for in vitro use
Depiction of human cells cultured on transwell inserts and exposed to aerosolized influenza 
virus using a previously characterized system (Gustin et al., 2011). Cell culture dishes rest in 
the exposure chamber on a wire shelf under air-liquid interface conditions for the duration of 
the exposure. Inset, individual transwell inserts are transferred to sterile plates once removed 
from the exposure chamber.
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Figure 2. Replication of influenza A viruses in Calu-3 cells
A) Calu-3 cells were infected by the traditional liquid route (dashed line) or the aerosol route 
(solid line) at the target MOI with the viruses shown, and cultured at 37°C or 33°C. Culture 
supernatants were collected at the indicated times p.i., and titers were determined by 
standard plaque assay to quantify infectious virus. The limit of detection was 10 PFU. Error 
bars indicate standard deviation. Lines represent positive wells (infectious virus detected at 
two sequential timepoints or at 96 hours alone, 3/3 unless otherwise noted) only. Cultures 
with 2/3 positive wells: Thai/16 33°C aerosol 1×10−6, liquid 1×10−7; Anhui/1 33°C aerosol 
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1×10−6, liquid 1×10−7; Panama/99 37°C aerosol 1×10−6. Cultures with 1/3 positive wells: 
Thai/16 37° liquid 1×10−8; Panama/99 33°C aerosol 1×10−5 and 1×10−6. B) Exact inoculum 
dose (PFU) and MOI for each infection shown in panel.
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Figure 3. Infection and replication in Calu-3 cells after aerosol exposure
A) Peak viral titers detected in each well inoculated via the aerosol route. Titers 
(log10PFU/mL) are provided for each well that showed evidence of productive replication, 
defined as infectious virus detected at two sequential timepoints or at 96 hours alone (full 
replication curves are shown in Fig. 2). Exposure dose (PFU) varied slightly between viruses 
and is therefore listed as a range. Exact exposure doses for each virus are listed in Table S1. 
Cells cultured at 33 and 37°C were exposed concurrently. CID50 indicates the 50% cellular 
infectious dose, or MOI required to achieve 50% infectivity, calculated by dividing ID50 by 
the cell number. Limit of detection was 10 PFU. B) Comparison of viral supernatant titer 
(left Y axis) and M copy number (right Y axis) present in the cell monolayer between 
aerosol and liquid inoculation at 24 hours p.i. Cells were cultured at 37°C. Supernatants 
were collected immediately prior to lysis of the cell monolayer for RNA collection. Each 
parameter is expressed as mean ± standard deviation of two independent wells. Limit of 
detection for M segment RNA was 10 copies.
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Figure 4. Replication of influenza A viruses in primary human alveolar epithelial cells
A) Peak viral titers detected in each well inoculated via the aerosol route, as described in the 
legend for Fig. 1A. B) Replication curves for Thai/16 aerosol inoculations shown in panel A. 
Titers shown represent mean ± standard deviation of three wells. C) Comparison of 
replication kinetics subsequent to aerosol or liquid inoculation of human primary alveolar 
epithelial cells. Cells were infected by the aerosol route (solid black line), or by the 
traditional liquid route (dotted line) at an MOI of 0.01 (gray) or 0.001 (black). Aerosol 
MOIs were 0.002, 0.0006, and 0.002 for Thai/16, Anhui/1, and Panama/99 viruses, 
respectively. Culture supernatants were collected at the indicated times p.i., and titers were 
determined by standard plaque assay to quantify infectious virus. The limit of detection was 
10 PFU. Mean ± SD from triplicate cultures (duplicate for Panama/99 liquid inoculum, 0.01 
MOI) is shown.
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Figure 5. Comparison of viral infectivity and replication between cells cultured at liquid-liquid 
(LLI) or air-liquid (ALI) interface
A) Peak viral titers detected in each well inoculated via the aerosol route, as described in the 
legend for Fig 3A. Exact exposure doses are listed in Table S2. Cells cultured at LLI and 
ALI were exposed concurrently and therefore have identical exposure doses. B) Replication 
curves from wells exposed to 116–260 PFU shown in panel A. Culture supernatants were 
collected at the indicated times p.i., and titers were determined by standard plaque assay to 
quantify infectious virus. The limit of detection was 10 PFU. Titers shown represent mean ± 
standard deviation of three wells (two in the case of Thai/16). Two-way ANOVA showed 
that overall titer differences between cells cultured at LLI and ALI were statistically 
significant (p<0.05). For each virus, titers from LLI and ALI wells were compared at each 
individual timepoint (p-values were adjusted for multiple comparisons using the Bonferroni 
correction): * indicates p < 0.05, ** indicates p < 0.001
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